Literature DB >> 25833141

The Parkinson's-associated protein DJ-1 regulates the 20S proteasome.

Oren Moscovitz1, Gili Ben-Nissan1, Irit Fainer1, Dan Pollack1, Limor Mizrachi1, Michal Sharon1.   

Abstract

The Parkinson's-associated protein, DJ-1, is a highly conserved homodimer, ubiquitously expressed in cells. Here we demonstrate that DJ-1 is a 20S proteasome regulator. We show that DJ-1 physically binds the 20S proteasome and inhibits its activity, rescuing partially unfolded proteins from degradation. Consequently, DJ-1 stabilizes the cellular levels of 20S proteasome substrates, as we show for α-synuclein and p53. Furthermore, we demonstrate that following oxidative stress, DJ-1 is involved in the Nrf2-dependent oxidative stress response that leads to the upregulation of both the 20S proteasome and its regulator, NQO1. Overall, our results suggest a regulatory circuit in which DJ-1, under conditions of oxidative stress, both upregulates and inhibits the 20S proteasome, providing a rigorous control mechanism at a time when the 20S proteasome becomes the major proteolytic machinery. Such a tight regulation of the 20S proteasome may sustain the balance between the need to rapidly eliminate oxidatively damaged proteins and maintain the abundance of native, intrinsically unstructured proteins, which coordinate regulatory and signalling events.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25833141     DOI: 10.1038/ncomms7609

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  51 in total

1.  The mitochondrial metabolic function of DJ-1 is modulated by 14-3-3β.

Authors:  Maria Weinert; Aurelie Millet; Elizabeth A Jonas; Kambiz N Alavian
Journal:  FASEB J       Date:  2019-04-29       Impact factor: 5.191

Review 2.  Mitochondrial dysfunction in protein conformational disorders.

Authors:  Shlomi Brielle; Daniel Kaganovich
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

3.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

4.  Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.

Authors:  Briana R De Miranda; Emily M Rocha; Qing Bai; Amina El Ayadi; David Hinkle; Edward A Burton; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2018-04-09       Impact factor: 5.996

Review 5.  Mitophagy in Human Diseases.

Authors:  Laura Doblado; Claudia Lueck; Claudia Rey; Alejandro K Samhan-Arias; Ignacio Prieto; Alessandra Stacchiotti; Maria Monsalve
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

6.  Dysregulation in the Brain Protein Profile of Zebrafish Lacking the Parkinson's Disease-Related Protein DJ-1.

Authors:  Amanda J Edson; Helena A Hushagen; Ann Kristin Frøyset; Inga Elda; Essa A Khan; Antonio Di Stefano; Kari E Fladmark
Journal:  Mol Neurobiol       Date:  2019-06-19       Impact factor: 5.590

7.  Intracellular metal binding and redox behavior of human DJ-1.

Authors:  Letizia Barbieri; Enrico Luchinat; Lucia Banci
Journal:  J Biol Inorg Chem       Date:  2017-12-07       Impact factor: 3.358

8.  A Two-step Protein Quality Control Pathway for a Misfolded DJ-1 Variant in Fission Yeast.

Authors:  Søs G Mathiassen; Ida B Larsen; Esben G Poulsen; Christian T Madsen; Elena Papaleo; Kresten Lindorff-Larsen; Birthe B Kragelund; Michael L Nielsen; Franziska Kriegenburg; Rasmus Hartmann-Petersen
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

Review 9.  Are we listening to everything the PARK genes are telling us?

Authors:  Deanna L Benson; George W Huntley
Journal:  J Comp Neurol       Date:  2019-02-08       Impact factor: 3.215

Review 10.  Parkinson's disease: experimental models and reality.

Authors:  Peizhou Jiang; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2017-11-18       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.